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Fumaria indica (Hausskn.) Pugsley, syn: F. parviflora Lam. (Fumariaceae) is a small,
scandent, branched annual herb growing wild in plains and lower hills. The plant is
considered to be diuretic, diaphoretic, anthelmintic, laxative and is used to purify blood
and in liver obstruction in ethnopharmacology (1, 2). Pharmacological studies show that
F. indica possesses antipyretic, antidiarrhoeal and hypoglycemic properties (3–5). It is a
smooth muscles relaxant and has hydrocholeretic, by stimulating bile excretion, and
hepatoprotective effects (6–10). Phytochemical investigation revealed the presence of al-
kaloids, viz. protopine (6), parfumine, cryptopine, copticine, fumariline (11), fumarami-
ne, fumaritine, paprafumicin, paprarine, papracinine, papraline, reddeanine (12), fuma-
rophycine (13), narlumicine, narceimine, narlumidine (14); steroids, viz. b-sitosterol,
stigmasterol, campesterol; organic acids viz. caffeic acid and fumaric acid (9, 13).
As there is no reference in literature to the anti-inflammatory aspects, it was consid-
ered worthwhile to study the anti-inflammatory and anti-nociceptive activity of the Fu-
maria indica whole plant.
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The 50% ethanolic extract of Fumaria indica was investi-
gated for its anti-inflammatory and antinociceptive po-
tential in animal models. Oral administration of F. indica
dry extract (100, 200 and 400 mg kg–1) exhibited dose de-
pendent and significant anti-inflammatory activity in
acute (carrageenean and histamine induced hind paw
oedema, p < 0.05) and chronic cotton pellet granuloma
models of inflammation, p < 0.01). The extract (400 mg
kg–1) exhibited maximum anti-inflammatory effects of
42.2 and 42.1% after 3 h with carrageenean and histami-
ne, respectively. The same dose of extract showed 38.9%
reduction in granuloma mass in a chronic condition. A
significant anti-nociceptive activity was evidenced in
mice; 6.6–67.7% (p < 0.01) protection in mechanical, 33.9–
125.1% (p < 0.05) protection in thermal induced pain and
22.2–73.9% (p < 0.05) protection in acetic acid-induced
writhing.
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EXPERIMENTAL
Plant material and extraction
Plants of F. indica were collected from the rural area around Lucknow, India. The
plant material was identified, authenticated taxonomically and a voucher specimen was
preserved in Pharmacognosy and Ethnopharmacology Division (NBR-21) for future re-
ference. Air-dried powdered material of F. indica (1000 g) was exhaustively extracted
with 10 volumes of 50% ethanol. This process of extraction was repeated four times, the
extract was filtered, concentrated on rotavapour (Büchi, USA) and then freeze-dried
(Freezone® 4.5, Labconco, USA) under high vacuum (1.33 Pa) and at temperature of –40
± 2 °C (yield 9.85%, m/m).
High performance thin layer chromatography (HPTLC)
The 50% ethanolic extract of F. indica was analyzed by TLC, which showed the pres-
ence of phenolics. Caffeic acid and 50% ethanolic extract of F. indica were spotted using a
Camag Linomat IV spotter on the precoated silica gel 60/UV254 HPTLC plates (Merck,
India) as stationary phase. The plate was eluted with toluene/ethyl acetate/formic acid
(70:30:10) as mobile phase. After development, the plates were dried and densitometri-
cally scanned on a TLC scanner III at 284 nm using WinCat software (CAMAG, Switzer-
land); the peak area was recorded and the calibration curve was prepared by plotting
the peak area against the concentration of caffeic acid applied.
Animals
Male Sprague-Dawley rats (150–175 g) and albino mice (25–30 g) were obtained
from the animal colony of the National Laboratory Animal Centre, Lucknow, India.
They were randomly distributed into groups and housed in cages (6 per cage) and main-
tained under standard conditions at 26 ± 2 °C and relative humidity 44–56% and 10 h
light 14 h dark cycles each day for one week before and during the experiments. All ani-
mals were fed the standard rodent pellet diet (Amrut, India) and drank water ad libitum.
All studies were performed in accordance with the guidelines for the care and use of
laboratory animals, as adopted and promulgated by the Institutional Animal Care Com-
mittee, CPCSEA, India.
Anti-inflammatory activity of 50% ethanolic extract of F. indica
The rats were divided into five groups of six animals each. The test groups received
the dry extract of F. indica (suspended in 1% caboxymethylcellulose, CMC) at doses of
100, 200 and 400 mg kg–1, p.o.; the reference group received phenylbutazone (100 mg kg–1,
in 1% CMC, p.o.) as positive control and the negative control animals received the vehi-
cle only (1% CMC, 10 mL kg–1, p.o.).
Carrageenean induced paw oedema. – The test was used to determine the anti-inflam-
matory activity of the extract by the method of Winter et al. (17). The animals pretreated
with extract or phenylbutazone one hour before were injected with 0.1 mL of 1% l carra-
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geenean (in 1% CMC) solution into the sub-plantar side of right hind paw. Paw volume
was measured by dislocation of the water column in a plethysmometer (Ugo Basile, It-
aly) immediately after l carrageenean application (time zero) and 3 h after the stimulus.
Reduction in the paw volume compared to the vehicle-treated control animals was con-
sidered as anti-inflammatory response.
Histamine-induced hind paw oedema. – This experiment was conducted as per the me-
thodology used by Parmar and Ghosh (16). Right hind paw oedema was induced by the
sub plantar injection of 0.1 mL of histamine (1 mg mL–1 in 1% CMC). Extract and phe-
nylbutazone were administered 1 h prior to the inflammatory insult. The paw volume
compared to that of the negative control animals was recorded after 3 h and considered
as anti-inflammatory response.
Cotton pellet-induced granuloma. – The test was performed on the rats using the cot-
ton pellet induced granuloma method (17). The rats were anesthetized under light ether
and an incision was made on the lumbar region by blunted forceps, a subcutaneous tun-
nel was made and a sterilized cotton pellet (100 ± 1 mg) was inserted in the groin area.
Groups of 6 animals received either extract or phenylbutazone or vehicle (1% CMC)
orally for seven consecutive days from the day of cotton pellet insertion. On the eighth
day animals were anesthetized again and cotton pellets were removed and dried to con-
stant mass (18).
Anti-nociceptive activity of 50% ethanolic extract of F. indica
Anti-nociceptive activity was assessed by analgesy meter induced pain (19), hot plate
reaction time (20) and abdominal writhing test using acetic acid (21) applied to male al-
bino mice. Animals of the negative control received the vehicle only (1% CMC, 10 mL
kg–1, p.o.).
Analgesy meter induced pain. – Analgesy meter induced pain was tested in mice using
an analgesy-meter (Ugo Basile). This method involved the application of force to the
paw using the analgesy meter, which exerts a force at a constant rate. The mice were
gently placed between the plinth and plunger. The instrument was switched on and con-
stant motor rate was used to drive the plunger onto the paw. When the mice struggled,
the instrument was switched off and the force at which the animal felt pain was read on
a scale. The pre and post treatment weight causing pain was determined for each mou-
se. F. indica extract as test drug (100, 200, and 400 mg kg–1, p.o.) and acetylsalicylic acid
(ASA, 25 mg kg–1, p.o.) as reference drug in 1% CMC were administered 30 min before
the test.
Hot plate reaction time. – Mice were screened by being placed on a hot plate main-
tained at 55 ± 1 °C and recording the reaction time in seconds for fore paw licking or
jumping. Only mice that reacted within fifteen seconds and did not show large variation
on three separate occasions, each fifteen minutes apart, were taken for the test. Reaction
time (paw licking, jumping) was measured initially and 30 min after intraperitoneal in-
jection of 10 mg kg–1 pentazocine (PZ) as a reference drug and F. indica extract in 1%
CMC (100, 200, and 400 mg kg–1) (20).
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Acetic acid-induced writhing test. – In the writhing test, 0.6% acetic acid (10 mg kg–1,
i.p.) was injected and the number of writhes and stretching with a jerk of the hind limb
were counted for a period of 15 min. Acetylsalicylic acid (ASA, 25 mg kg–1, p.o.) or the F.
indica extract in 1% CMC (100, 200, and 400 mg kg–1) were administered orally 30 min
before acetic acid injection (21).
Statistical analysis
All the data are presented as mean ± SEM and one-way analysis of variance (ANO-
VA) and Newman-Keuls Multiple Comparision Test were applied for determining the
statistical significance between different groups.
RESULTS AND DISCUSSION
Phytochemical screening
Preliminary qualitative phytochemical screening of F. indica showed the presence of
alkaloids, flavonoids, glycosides, tannins, saponins, steroids and triterpenoids.
Earlier studies on this plant by Sousek et al. (12) reported the presence of organic
acids. Hence, we made an attempt to quantify the caffeic acid in F. indica.
Concentration of caffeic acid (396 mg g–1 extract) present in 50% ethanolic extract of
F. indica was estimated.
Anti-inflammatory activity of 50% ethanolic extract of F. indica
Treatment with different doses of F. indica showed a dose-dependent inhibition of
swelling caused by l carrageenean after 3 h equivalent to 13.6 to 42.2% protection in
comparison with the negative control, whereas phenylbutazone at the dose of 100 mg
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Table I. Effect of 50% ethanolic extract of F. indica on carrageenean and histamine induced
paw oedema in rats
Treatment
Carrageenean induced Histamine induced
Paw volume
(mL)
Inhibition
(%)
Paw volume
(mL)
Inhibition
(%)
Negative control (1% CMC,
10 mL kg–1)
1.18 ± 0.05 – 1.26 ± 0.03 –
F. indica (100 mg kg–1) 1.02 ± 0.04a 13.6 1.11 ± 0.05a 11.2
F. indica (200 mg kg–1) 0.89 ± 0.03b 24.7 1.00 ± 0.02b 20.6
F. indica (400 mg kg–1) 0.67 ± 0.03b 43.2 0.73 ± 0.03b 42.1
Phenylbutazone (100 mg kg–1) 0.66 ± 0.05b 44.1 0.71 ± 0.06b 43.2
Mean ± SEM for six rats per group.
a p < 0.05, b p < 0.001 compared to negative control.
kg–1 showed 44.1% anti-inflammatory activity (Table I). The F. indica extract at doses of
100, 200 and 400 mg kg–1 reduced the oedema induced by histamine by 11.2 to 42.1%
respectively, whereas phenylbutazone decreased by oedema 43.2% (Table I). The study
of F. indica extract on cotton pellet granuloma in rats indicated that F. indica (100, 200 and
400 mg kg–1, p.o.) significantly (p < 0.01) reduced the granuloma formation by percent
inhibition of 16.7 to 38.9% compared to the control. Phenylbutazone showed significant
(p < 0.001) inhibition of granuloma formation by percent inhibition of 40.1% (Table II).
Anti-nociceptive activity of 50% ethanolic extract of F. indica
The experimental data of the force-induced pain indicates that the mice treated with
F. indica extract exhibited resistance against pain after 30 min equivalent to 17.4 to 57.3%
at different doses compared to the control (Fig. 1). F. indica extract at the dose of 100 mg kg–1
increased the hot plate reaction time by 33.9%. However, dose levels of 200 and 400 mg
kg–1 increased the reaction time significantly (p < 0.01) and percent protection by 73.2%
and 125.1%, respectively (Fig. 2). F. indica extract showed inhibition of the writhing res-
ponse induced by acetic acid dose dependently (100, 200 and 400 mg kg–1), which resulted
in greater inhibition of stretching episodes; the protection ranged from 27.0 to 53.5%,
whereas and acetylsalicylic acid blocked the writhing response by 63.1% (Table III).
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Table II. Effect of 50% ethanolic extract of F. indica on cotton pellet induced granuloma in rats
Treatment Dry mass (mg) Inhibition (%)
Negative control (1% CMC, 10 mL kg–1) 36.8 ± 1.9 –
F. indica (100 mg kg–1) 30.6 ± 1.2a 16.9
F. indica (200 mg kg–1) 27.3 ± 1.6b 26.0
F. indica (400 mg kg–1) 22.5 ± 1.5b 38.9
Phenylbutazone (100 mg kg–1) 22.1 ± 1.1b 40.1
Mean ± SEM for six rats per group.
a p < 0.01, b p < 0.001 compared to negative control.
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Fig. 1. Effect of 50% ethanolic ex-
tract of F. indica on force induced
pain in mice.
Mean ± SEM for six mice per group.
a p < 0.01, b p < 0.001 compared to
negative control.
a b
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The present study demonstrates the anti-inflammatory activity of the 50% ethanolic
extract of F. indica in different models of inflammation-acute exudative and proliferative
phases of inflammation. Dose of 400 mg kg–1 shows anti-inflammatory and anti-noci-
ceptive effect to standard drugs. Caffeic acid is one of the phenolics present in F. indica,
which was reported to possess anti-inflammatory activity (22). On the other hand, b-si-
tosterol has also been reported as an anti-inflammatory, analgesic and antipyretic agent
(23, 24). Therefore, caffeic acid and b-sitosterol may be responsible for the anti-inflam-
matory and anti-nociceptive effects exhibited by F. indica. The ability of the F. indica ex-
tract in analgesic activity may be due to the involvement of prostaglandins and other
mediators in a different order of magnitudes. The capacity of prostaglandin to sensitize
pain receptors to mechanical and chemical stimulation appears to result from a lowering
of the threshold after F. indica treatment.
CONCLUSIONS
Based on the present study, it can be concluded that F. indica has potential anti-in-
flammatory activity against both exudative (carrageenean and histamine induced in-
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Fig. 2. Effect of 50% ethanolic extract
of F. indica on hot plate reaction time
in mice.
Mean ± SEM for six mice per group.
a p < 0.05, b p < 0.01, c p < 0.001 com-
pared to negative control.
Table III. Effect of 50% ethanolic extract of F. indica on acetic acid induced writhing in mice
Treatment Number of writhings Inhibition (%)
Negative control (1% CMC, 10 mL kg–1) 26.7 ± 2.7 –
F. indica (100 mg kg–1) 19.5 ± 2.2a 27.0
F. indica (200 mg kg–1) 15.3 ± 1.2b 42.6
F. indica (400 mg kg–1) 12.4 ± 1.7c 53.5
Acetylsalicylic acid (25 mg kg–1) 9.9 ± 1.6c 63.1
Mean ± SEM for six mice per group.
a p < 0.05, b p < 0.01, c p < 0.001 compared to negative control.
a
b
c
flammation) and proliferative (cotton pellet induced granuloma) phases of inflamma-
tion; the extract also showed anti-nociceptive activity, mediated both centrally and
peripherally. F. indica extract significantly raised the pain threshold. This offers a new
perspective in the treatment of pain. Further studies are in progress and are aimed to
identify all active constituents responsible for the anti-inflammatory and anti-nocicep-
tive properties.
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S A  E T A K
Protuupalno i analgetsko djelovanje ekstrakta cijele biljke Fumaria indica
na eksperimentalnim ivotinjama
CHANDANA VENKATESWARARAO RAO, ARTI RAJ VERMA, PRAKSH KUMAR GUPTA i MADHAVAN VIJAYAKUMAR
Na animalnom modelu ispitivano je protuupalno i analgetsko djelovanje ekstrakta
biljke Fumaria indica sa 50%-tnim etanolnom. Peroralna primjena suhog ekstrakta F. in-
dica (100, 200 i 400 mg kg–1) pokazuje zna~ajno i o dozi ovisno protuupalno djelovanje
na akutni (edem šape uzrokovan karagenom i histaminom, p < 0.05) i kroni~ni upalni
proces (granulomi uzrokovani pamu~nim peletama, p < 0.01). Najve}i protuupalni u~i-
nak u karagenskom, odnosno histaminskom testu od 42,2 i 42,1% dobiven je s dozom
400 mg kg–1 nakon 3 h. Ista doza ekstrakta pokazala je 38,9% smanjenje mase granu-
loma. Zna~ajno analgetsko djelovanje dokazano je pokusima na miševima: 6,6–67,7% (p
< 0,01) zaštita od mehani~ki izazvane boli, 33,9–125,1% (p < 0,05) zaštita od termi~ki iza-
zvane boli i 22,2–73,9% (p < 0,05) zaštita od kemijski izazvane boli octenom kiselinom.
Kljuène rijeèi: Fumaria indica (Fumariaceae), protuupalno djelovanje, analgetsko djelovanje
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